Articles tagged with Viral Infections
A new AI model called druGAN enables the generation of novel molecules with desired properties, surpassing previous GAN-based approaches. The model uses reinforcement learning to generate effective molecular graphs, paving the way for improved pharmaceuticals.
Researchers at NYU School of Medicine discovered that calcium flow into cells controls the activation of genes involved in glucose metabolism, enabling T cells to multiply. The study's findings have implications for autoimmune diseases and may lead to new treatments.
A new study reveals how rabies induces frenzied behavior in animals by binding to and inhibiting brain receptors, leading to the transmission of the disease. The research provides a molecular mechanism for this behavior change, shedding light on why rabies is devastating in poor, rural regions.
A study by University of Utah Health found that 7% of US athletes and staff infected with mosquito-borne viruses during the 2016 Rio Olympics were positive for West Nile virus, Dengue fever, and Chikungunya. Most had mild symptoms or no symptoms at all, highlighting the importance of post-travel diagnostics.
Scientists develop an antibody-based Zika virus therapeutic that protects monkeys from infection and neutralizes the virus. The treatment has been shown to be effective in preventing Zika virus replication in rhesus macaques.
A collaborative study has found that a combination of three monoclonal antibodies prevents Zika virus infection in primates. The treatment completely blocked the virus from taking hold in the animals, indicating a promising intervention to protect uninfected pregnant women and their fetuses.
The Congenital Zika Virus Program at Children's National evaluated 36 women and their fetuses, revealing that 89% had been bitten by Zika-tainted mosquitoes or exposed via sex with an infected partner. Tragically, four fetuses suffered severe birth defects, leading to two non-viable pregnancies and one infant death.
A new DNA-based Zika vaccine candidate has demonstrated both safety and the ability to elicit an immune response against Zika in humans. The phase 1 clinical trial showed that participants produced an immune response against Zika with minimal adverse effects.
Researchers at the University of Nebraska-Lincoln have identified a Zika virus mutation that contains a sugar in its protein envelope, which may help the virus enter the brain. This discovery could explain why the virus became more lethal during outbreaks in the Caribbean and South America.
A phase 1 clinical trial demonstrated the safety and ability of a new DNA-based Zika vaccine to elicit an immune response against the virus, with 100% of participants developing Zika-specific antibodies. The vaccine also showed promise in preventing infection in immunocompromised mice.
A new study by Midwestern University found that physical and occupational therapists are at increased risk of contracting CMV due to lack of knowledge on prevention methods. The study highlights the need for educational initiatives to address the knowledge gap among these healthcare professionals.
Researchers identified a tiny viral protein, 3B3, that plays a key role in the replication of foot-and-mouth disease virus. This discovery could lead to the development of more effective vaccines against the disease.
A study published in Nature Immunology has found that a specific type of immune cell, called T follicular regulatory cells, plays a crucial role in preventing autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus after viral infections. These cells prevent the generation of self-reactive antibody responses whil...
Researchers at Cleveland Clinic found that TRPV1 protein plays a critical role in airway disease through mucus production, cough reflex stimulation and airway narrowing. The study suggests that targeting this protein may lead to new strategies to reduce the impact of RSV infections in both asthmatic and non-asthmatic children.
A new study identifies RC-101 as a potential protective agent against flu and other infections. The protein targets the virus and inflammation, improving symptoms and mortality rates in animal models.
Researchers identified retrocyclin-101 (RC-101) as a potential protective agent against flu infection, showing improved symptoms and reduced mortality in animal models. RC-101 targets the influenza virus and inflammation, offering a new tool in the fight against this deadly disease.
Researchers at Scripps Research Institute developed artificial peptide molecules that neutralize a broad range of influenza virus strains. The peptides show high binding affinity and potent ability to neutralize infections with these viruses.
A recent study has found that natural killer cells play an important role in protecting against CMV-induced hearing loss in mice. The interaction between NK cells and the viral protein m157 is crucial in preventing hearing loss, with mice lacking this interaction being more susceptible to hearing loss.
New study reveals integrated HBV DNA as a significant source of HBsAg, expanding understanding of HBV biology and host interactions. The findings have important implications for future trial design and endpoint expectations for new therapies developed to cure chronic HBV.
Researchers at the University of Hawaii aim to develop strategies to prevent Zika virus transmission to the fetus and treat patients infected with the virus. Dr. Mukesh Kumar will work on understanding how the virus is transmitted and developed effective therapeutics.
The Center for Solutions for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (CfS for ME/CFS) will pursue basic research and develop tools to monitor illness progression, while working closely with the ME/CFS community through partnerships and outreach.
Researchers found that the Ebola virus exploits a protein called Tim-1 in T-cells to spread and cause disease. The study suggests that blocking this protein could lead to effective treatments for Ebola.
A potential Zika vaccine has shown to completely prevent infection, transmission from pregnant mothers to developing fetuses and protect males against testicular infection and injury. The vaccine also prevents a lowered sperm count after one vaccination.
A new study shows an antibody that prevents dengue disease also protects mice from Zika. Administering the antibody soon after infection can protect fetuses from Zika-related birth defects.
Scientists discovered that antibodies taken from dengue patients are effective in treating zika infection in rodents and even protect unborn pups. The discovery could lead to a single therapy to protect against both viral threats if replicated in humans.
A study by Northeastern University expert Marco Ajelli found that people who spend less time outdoors are less likely to contract the Zika virus. However, a small group of people who spend large amounts of time outdoors are at high risk for infection and can spread the disease quickly.
Researchers used PET imaging to study brain inflammation following Zika virus infection in mice, finding a 2- to 6-fold increase in global brain neuroinflammation over time. The technology allows for longitudinal studies of the same animal during the course of the infection, providing enhanced information about disease progression.
Researchers test antiviral therapy to halt progressive hearing loss in children with confirmed CMV infection, finding that treatment may prevent further damage and improve outcomes for those infected.
A new EHR-based prompt increased HCV screening rates among baby boomers from 7.6% to 72%, while also facilitating follow-up care for infected patients. The streamlined process led to a significant increase in HCV treatment prescriptions, with 67% of newly diagnosed patients receiving curative treatment.
New research reveals sepsis disrupts immune system function by impairing TRM recruitment to infected skin, increasing risk of life-threatening secondary infections. In mice, sepsis stymied TRM's ability to recruit bystander T and B cells to fight infection.
Two new studies published in the Journal of AAPOS found that all 70 infants with suspected and confirmed CZS had visual impairment, regardless of ocular abnormalities. Cortical visual impairment may be the most common cause of blindness among children with CZS.
Researchers use viral kinetic models to increase understanding of influenza biology and antiviral pharmacology, identifying sources of variation between individuals. These models have been used to support dose optimization and clinical development of potential influenza therapies.
A recent study explores how infectious hematopoietic necrosis virus (IHNV) spreads among juvenile hatchery-raised fish in the Pacific Northwest. Modeling reveals that returning adults and within-hatchery juvenile-to-juvenile transmission are efficient pathways of IHNV spread.
A multi-center study found significant racial and ethnic differences in antibiotic prescribing for viral acute respiratory tract infections in pediatric Emergency Departments. Non-Latino white children were nearly twice as likely to receive antibiotics, while Latino and black children received lower rates of unnecessary prescriptions.
Researchers at the University of Texas Medical Branch have developed a treatment for Lassa fever that provides 100% protection against the deadly virus in nonhuman primates, even when administered up to eight days after exposure. The treatment uses monoclonal antibodies and has been shown to be well-tolerated.
Researchers found that Zika virus can kill glioblastoma stem cells, which are resistant to standard treatments. The virus targets these cells without harming noncancerous brain cells, making it a promising potential treatment option.
Researchers identified distinct gene expression patterns and immune signatures associated with asymptomatic dengue infections, revealing a supporting role for T cell protection. These findings could optimize vaccine development efforts by understanding what types of immune responses are important in defending the body against the disease.
A team of researchers discovered a way to treat severe inflammation from mosquito-borne diseases like Chikungunya and Ross River virus. They developed an NLRP3 inhibitor drug MCC950, which provided significant relief from inflammation and disease in infected mice.
Researchers identify MARCO as a key adenovirus receptor on macrophage cells, enabling viral invasion and triggering an inflammatory response. This discovery has implications for gene therapy and the development of medications to block the receptor
A new study found that Zika virus preferentially replicates in the female reproductive tract after vaginal transmission, suggesting a higher risk of fetal Zika disease. The research used rhesus macaques to investigate the effects of mosquito and sexual transmission on Zika infection.
Researchers at NIH's National Institute of Allergy and Infectious Diseases have developed a laboratory model to study tick-borne flaviviruses, including Powassan virus. The new model involves culturing organs from Ixodes scapularis ticks with flaviviruses, which can infect salivary glands and midgut.
Researchers from the University of Exeter have discovered a virus that can reprogram ocean plankton to absorb certain nutrients, potentially affecting carbon storage in the ocean. The study found that infected phytoplankton cells become more competitive and grow faster before being killed by the virus.
Researchers found that avian flu viruses isolated from humans have the same gene sequences as those from birds, suggesting transmission through the mineral layer. The mineralized shell changes the electric surface potential of the virus, allowing it to adsorb efficiently onto host cells.
Researchers from the University of Basel have identified messenger substances that trigger excessive inflammatory responses in infected mice, leading to circulatory failure. Blocking these substances with existing medications may help prevent fatal outcomes in viral hemorrhagic fevers.
A new mechanism has been discovered that allows white blood cells to recognize and expel pathogens, preventing the spread of infections like Cryptococcosis to the brain. Researchers have identified a key molecule called ERK5 that can be manipulated to enhance this process, offering potential therapies for diseases such as this.
A Penn State researcher has received a $1.9 million grant to develop a genetic lab tool using a mosquito virus to control malaria. The virus, called AgDNV, will be used to insert specific genes into mosquitoes, allowing scientists to study their phenotypes and develop malaria-control strategies.
A new study by Ohio State University researchers highlights the need for protective measures to prevent pig-to-human flu transmission at fairs. The study found that shorter exhibition lengths and proper hygiene practices can significantly reduce disease transmission.
A new study by Texas Tech University Health Sciences Center El Paso researchers explores the impact of prior West Nile virus exposure on Zika infection. The team collected blood samples from 500 individuals and tested for West Nile antibodies to determine whether previous exposure could inhibit or enhance Zika infection severity.
A single-center study in Brazil found Zika virus infection associated with a diverse spectrum of serious neurologic syndromes, including Guillain-Barré syndrome and encephalitis. The study suggests serologic and molecular testing as an alternative diagnostic strategy in developing countries.
A team of researchers has created a three-dimensional movie showing a virus preparing to infect a healthy cell. The study uses powerful algorithms and X-ray imaging equipment to reveal the sequential images of the virus's molecular machinery. The findings provide new insights into how viruses undergo changes during infection.
Researchers developed a test that detects Zika virus presence in blood in minutes, using gold nanorods on paper. The test relies on an immune response caused by the virus and doesn't require refrigeration, making it suitable for resource-limited settings.
A study shows that Alaska's universal hepatitis B vaccination programme has wiped out hepatitis B infection and liver cancer cases in the state's young people. The program, introduced in the 1980s, led to a significant decrease in acute symptomatic HBV infection and liver cancer cases among Alaskan Native children, with no reported cas...
A new meta-analysis reveals that Indigenous Peoples are significantly more likely to contract viral hepatitis due to factors like poverty, injection drug use, and lack of access to healthcare. The study shows disparities in prevalence rates across North America, South America, Australia, and New Zealand.
A clinical trial has demonstrated the safety and effectiveness of a new treatment using virus-specific cells to treat viral infections in patients who have received a hematopoietic stem cell transplant. The treatment resulted in an overall complete or partial response rate of 92% in patients with severe, drug-resistant viral infections.
Researchers found that populations of males who have sex with males can form an outbreak-sustaining core, while heterosexual populations experience smaller outbreaks. This raises concerns about silent, sustained outbreaks in the community, particularly among men who are least likely to get tested for Zika.
A new study shows that a particular gut microbe can prevent severe flu infections in mice by breaking down flavonoids, which are commonly found in foods like black tea and blueberries. The research identifies a specific metabolite called desaminotyrosine that enhances interferon signaling, reducing lung damage from flu infection.
Researchers have developed a mouse model to study Zika virus transmission, finding that the virus can be transmitted sexually from males to females and vertically from pregnant women to their fetuses. The study suggests that the placenta may be a key barrier in preventing Zika virus infection of the fetus.
Climate change may exacerbate epidemics and spread diseases within their natural range, according to a new study on European pathogens. Nearly two-thirds of the top 100 human and animal pathogens are found to be sensitive to climate change.
Researchers at the University of North Carolina Health Care found that Ebola virus RNA can persist in the semen of survivors for more than two years after infection. This persistence has important implications for transmission and may require an update to World Health Organization guidelines.
The University of Delaware has received $6 million in grants from the National Science Foundation to study how viruses impact microbes, with a focus on improving crop yields and developing new drug therapies. The research team will develop microfluidics technology to examine single virus-cell and microbial interactions.